Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Interventional radiology · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Zhao Ming赵明

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Zhao Ming

Professional overview

Dr. Zhao Ming is a Chief Physician and Professor at Sun Yat-sen University Cancer Center, specializing in image-guided minimally invasive interventional therapy for solid tumors, particularly hepatocellular carcinoma.

SpecialtyInterventional radiology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentMinimally Invasive Interventional Therapy Department
HospitalSun Yat-sen University Cancer Center
CityGuangzhou
Hospital roleDeputy Director, Minimally Invasive Interventional Therapy Department

Areas of focus

Liver cancerPercutaneous ablation (radiofrequency, microwave, cryoablation) under CT/MRI guidance for early and early recurrent hepatocellular carcinoma
Liver cancerHepatic arterial infusion chemotherapy (HAIC) with FOLFOX regimen for unresectable intermediate- to advanced-stage hepatocellular carcinoma
Liver cancerCombined modality treatment including transarterial chemoembolization (TACE), ablation, immunotherapy (anti-PD-1/PD-L1), and targeted therapy (lenvatinib) for advanced hepatocellular carcinoma

Background

  • 2007Served as Associate Chief Physician and Associate Professor at Sun Yat-sen University Cancer Center; Master's Supervisor
  • 2008Clinical training at Barcelona Clinic Liver Cancer (BCLC) Research Center
  • 2011Visiting Scholar in tumor immunology and translational medicine at Brigham and Women’s Hospital, Harvard University
  • 2012Visiting Scholar in tumor immunology and translational medicine at Brigham and Women’s Hospital, Harvard University
  • 2013Appointed Chief Physician at Sun Yat-sen University Cancer Center
  • 2017Appointed Professor at Sun Yat-sen University; became Doctoral Supervisor
  • 2020Became Deputy Director of the Minimally Invasive Interventional Therapy Department at Sun Yat-sen University Cancer Center
  • 2023Appointed Third-Tier Professor and Second-Tier Chief Physician

Experience & recognition

  • FOLFOX-based hepatic arterial infusion chemotherapy (HAIC) included in National Health Commission's Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2019, 2021, 2022) and CSCO Guidelines for Hepatocellular Carcinoma (2018, 2020, 2022)
  • Participated in drafting the 2018 and 2020 editions of CSCO Guidelines for Hepatocellular Carcinoma and the 2020 Expert Consensus on Multidisciplinary Treatment of Liver Cancer in China
  • First author or corresponding author of over 50 papers, including publications in Journal of Clinical Oncology, GUT, Journal of Hepatology, and Radiology
  • Principal investigator of multiple national and provincial research grants, including two National Natural Science Foundation of China (NSFC) projects

Professional roles

  • Chair, Chemotherapy and Immunotherapy Committee, Interventional Therapy Society, China Anti-Cancer Association (CACA)
  • Standing Committee Member, Hepatocellular Carcinoma Committee, Chinese Clinical Oncology Society (CSCO)
  • Standing Committee Member, Interventional Therapy Committee, Chinese Clinical Oncology Society (CSCO)
  • Member, Hepatocellular Carcinoma Committee, China Anti-Cancer Association (CACA)
  • Standing Committee Member, Ablation Expert Committee, Interventional Therapy Committee, China Anti-Cancer Association (CACA)
  • Vice Chair, Hepatobiliary Tumor Committee, Beijing Asia-Pacific Association for Liver Disease Diagnosis and Treatment
  • Standing Committee Member, Ultrasound Intervention and Tumor Ablation Collaboration Committee, Chinese Medical Doctor Association (CMDA)
  • Chair, Minimally Invasive Therapy Committee, Guangzhou Anti-Cancer Association

Frequently asked questions

What does Dr. Zhao Ming specialize in?

Specializes in image-guided minimally invasive interventional therapy for liver cancer, including percutaneous ablation, hepatic arterial infusion chemotherapy (HAIC) with FOLFOX, and combined modality treatment integrating TACE, immunotherapy, and targeted therapy.

Which hospital and department is Dr. Zhao Ming in?

Minimally Invasive Interventional Therapy Department at Sun Yat-sen University Cancer Center

Sources

Dr. Zhao Ming has not reviewed this page.